Medication for patient-athletes-the therapeutic use exemption procedure

Caterina Fiorentini¹, Katrin Esefeld^{1

2}, Martin Halle^{1

2}

Affiliations

¹ Department of Prevention and Sports Medicine, University hospital Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 56/58, Munich 80992, Germany.
² DZHK (German Center for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Potsdamer Str. 58, 10785 Berlin, Germany.

Editorial

Caterina Fiorentini et al. Eur J Prev Cardiol. 2022.

. 2022 Mar 25;29(3):556-558.

doi: 10.1093/eurjpc/zwac005.

Caterina Fiorentini¹, Katrin Esefeld^{1

2}, Martin Halle^{1

2}

¹ Department of Prevention and Sports Medicine, University hospital Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 56/58, Munich 80992, Germany.
² DZHK (German Center for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Potsdamer Str. 58, 10785 Berlin, Germany.

No abstract available

Comment on

Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology.
Adami PE, Koutlianos N, Baggish A, Bermon S, Cavarretta E, Deligiannis A, Furlanello F, Kouidi E, Marques-Vidal P, Niebauer J, Pelliccia A, Sharma S, Solberg EE, Stuart M, Papadakis M. Adami PE, et al. Eur J Prev Cardiol. 2022 Mar 25;29(3):559-575. doi: 10.1093/eurjpc/zwab198. Eur J Prev Cardiol. 2022. PMID: 35081615 Review.